CnOpenData 全球专利被文献引用信息表

时间区间

截止至2022.12.31


字段展示

全球专利被文献引用信息表
专利ID
引用专利的文献名称

样本数据

专利ID引用专利的文献名称
KR100208396B11981년, John Wiley & Sons, Inc. 발행, 지은이: T.Y.LIN & NED H.BURNS, 프리스트레스 콘크리트 구조물의 설계(Design of Prestressed Concrete Structures), 제3판 24쪽-26쪽 및 405쪽-408쪽 *
KR100208396B11995.1.10, 청문각 발행, 양창현 저, 구조역학, 제4판 411쪽-414쪽 *
KR100215090B1Biochem. Biophy. Res. Commun.., vol.139, pp.52-55 (1986) *
KR100215091B1Biochem. Biophy. Res. Comm., vol.139, pp.52-55 (1986) *
KR100217767B1J Acquir Immune Defic Syndr Hum Retrovirol 1996 Dec 1;13 *
KR100218586B1Electronics, Vol.56, No.14 제133쪽-135쪽의 "Optocoupler simulates laser-photodide assembly" (1983. 07. 14) *
KR100218897B1The Korean Journal of Microbiology Vol.25, No2, p133-142 , 이재성 외 7인 *
KR100220256B1Hematol Oncol Clin North Am 1990, Feb; (1):27-42 *
KR100220401B1국내 특허공보86-570(1986.5.17) *
KR100220402B1FEMS Microbiol Lett 1996 Sep 1;142(2-3) *
KR100220402B1J Antibiot (Tokyo) 1996 Feb *
KR100220828B1이유서 1부(2쪽) *
KR100222390B1Microbiol Rev 1991 Mar;55(1) *
KR100222419B1J Basic Microbiol 1987 ; 27(3) *
KR100222419B1J Dairy Sci 1994 Feb *
KR100222669B1William c. y. Lee, Mobile celllar tele. Systems, 1989년 *
KR100222669B1William c. y. Lee, Mobile comm. Design Fundamentals, 1986년 *
KR100224475B1Antibiot Med Biotekhnol 1986 Oct ;31 (10 ) *
KR100224475B1Prik Biokhim Mikrobio 1992 Sep - Oct *
US10000443B2Amendment in U.S. Appl. No. 13/071,386 dated Jun. 18, 2015.
US10000443B2Amendment in U.S. Appl. No. 13/071,386 dated Jun. 25, 2013.
US10000443B2Cairns, et al., "Metabolic targeting of hypoxia and HIF1 in solid tumors can enhance cytotoxic chemotherapy", Proc. Natl. Acad. Sci. U.S.A., (2007), vol. 104, No. 22, pp. 9445-9450.
US10000443B2CAS STN Abstract for Effenberger et. al., publ. 1991, CAS RN# 128924-03-8; RN# 128924-04-9. *
US10000443B2Chabner et al., Nature Reviews Cancer (2005), Nature Publishing Group, vol. 5, pp. 65-72.
US10000443B2Chabner et. al., Nature Reviews Cancer, 2005, Nature Publishing Group, vol. 5, pp. 65-72. *
US10000443B2Chan, et al., "Targeting GLUT1 and the Warburg Effect in Renal CellCarcinoma by Chemical Synthetic Lethality," Science Translational Medicine, (Aug. 3, 2011), vol. 3, 94ra70, pp. 1-9.
US10000443B2Communication pursuant to Article 94(3) EPC for EP Application No. 11760242.5 dated Jul. 21, 2016.
US10000443B2Communication pursuant to Rules 70(2) and 70a(2) EPC for EP Application No. 11760242.5 dated Dec. 19, 2013.
US10000443B2Cui et. al., CAS STN Abstract, publ. 2007. *
US10000443B2Effenberger et al., "Nucleophile Substitution von Nitrit in Nitrobenzolen, Nitrobiphenylen and Nitronaphtalien," Chemische Berichte, VCH, vol. 124, pp. 163-173 (Jan. 1, 1990).
US10000443B2Elstrom, et al., "Akt stimulates aerobic glycolysis in cancer cells", Cancer Res., (2004), vol. 64, pp. 3892-3899.
US10000443B2Bahr et al., "Dendritic, 1,1′-binaphthalene-derived cleft-type receptors (Dendroclefts) for the molecular recognition of pyranosides," Hevletica Chimica Acta (2000), vol. 83, No. 7, pp. 1346-1376.
US10000443B2English Translation of First Office Action for Chinese Patent Application No. 201180025712.3, dated Jan. 13, 2014.
US10000443B2English Translation of Second Office Action for Chinese Patent Application No. 201180025712.3 dated Nov. 15, 2014.
US10000443B2English Translation of Third Office Action for Chinese Patent Application No. 201180025712.3 dated Jul. 1, 2015.
US10000443B2Fantin, et al. "Mitochondriotoxic compounds for cancer therapy", Oncogene, (2006), vol. 25, pp. 4787-4797.
US10000443B2Fantin, et al., "Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance", Cancer Cell, (Jun. 13, 2006), vol. 9, No. 6, pp. 425-434.
US10000443B2Final Rejection in U.S. Appl. No. 13/071,386 dated Sep. 16, 2013.
US10000443B2Folkman, et al., "Cancer without disease," Nature, (2004), vol. 427, p. 787.

数据更新频率

年度更新

  • 19
    点赞
  • 19
    收藏
    觉得还不错? 一键收藏
  • 0
    评论
评论
添加红包

请填写红包祝福语或标题

红包个数最小为10个

红包金额最低5元

当前余额3.43前往充值 >
需支付:10.00
成就一亿技术人!
领取后你会自动成为博主和红包主的粉丝 规则
hope_wisdom
发出的红包
实付
使用余额支付
点击重新获取
扫码支付
钱包余额 0

抵扣说明:

1.余额是钱包充值的虚拟货币,按照1:1的比例进行支付金额的抵扣。
2.余额无法直接购买下载,可以购买VIP、付费专栏及课程。

余额充值